1 |
Hillary VE, Ceasar SA. An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines. Heliyon 2023;9:e13952. [PMID: 36855648 DOI: 10.1016/j.heliyon.2023.e13952] [Reference Citation Analysis]
|
2 |
Ricci A, Roviello GN. Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV. Life (Basel) 2023;13. [PMID: 36836758 DOI: 10.3390/life13020402] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Dhawan M, Rabaan AA, Fawarah MMA, Almuthree SA, Alsubki RA, Alfaraj AH, Mashraqi MM, Alshamrani SA, Abduljabbar WA, Alwashmi ASS, Ibrahim FA, Alsaleh AA, Khamis F, Alsalman J, Sharma M, Emran TB. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines (Basel) 2023;11. [PMID: 36679947 DOI: 10.3390/vaccines11010101] [Reference Citation Analysis]
|
4 |
Virgilio E, Tondo G, Montabone C, Comi C. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature. Int J Environ Res Public Health 2022;20. [PMID: 36612789 DOI: 10.3390/ijerph20010467] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Peshevska-Sekulovska M, Bakalova P, Snegarova V, Lazova S, Velikova T. COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease. Vaccines (Basel) 2022;10. [PMID: 36560485 DOI: 10.3390/vaccines10122075] [Reference Citation Analysis]
|